Below is a compiled list of scientific research and studies on Cannabidiol (CBD) and it’s potential use for treating Multiple Sclerosis (MS).
- Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
- Neurological Aspects of Medical Use of Cannabidiol
- Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice.
- Evaluating Sativex ® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis
- Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
- Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
- THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
- Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
- Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
